Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.91 +0.72%   SPY: 135.36 +0.13%
Quote Spy BIOD NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Biodel (BIOD)

@ 3:59 PM
Click the portfolio to add BIOD:
Close [X]
+ Add BIOD to Portfolio
  
  Last Trade: $0.66 +0.02 (2.97%)
  Volume: 1,348,381 605% of avg daily volume
       
  Avg Volume: 222,798
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.63 - 0.72
  Open: 0.65
  Previous Close: 0.64
  52-wk Range: 0.51 - 2.59
  Market Cap: 23.5M
  P/E: -1.9
  Div Yield: $0.00 (0.00%)
Indexes
Diabetes Stocks (-2.1%)
Spy BIOD

? Pro holders
? Member holders
? Items submitted
Additional BIOD resources



Customize Links
To see which Pros and tickerspy members own BIOD Sign up now
Latest BIOD Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Biodel Reports First Quarter Fiscal Year 2012 Financial Results
BIOD  
Posted by PR Newswire - February 08, 04:00PM

DANBURY, Conn., Feb. 8, 2012 /PRNewswire/ -- Biodel Inc.  more ...
Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Committee for Orphan Medicinal Products Recommends Orphan Designation for Biodel's Stabilized Glucagon for the Treatment of Congenital Hyperinsulinism
BIOD  
Linked by GlobeNewswire - January 20, 07:00AM from (www.globenewswire.com)
DANBURY, Conn., Jan. 20, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today reported that the European Medicines Agency's  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Biodel Reports Fourth Quarter Fiscal Year 2011 Financial Results
BIOD  
Posted by PR Newswire - December 06, 04:06PM

DANBURY, Conn., Dec. 6, 2011 /PRNewswire/ -- Biodel Inc.  more ...
Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Biotech news to note(8/4/11); overall market in bear mode
SPPI  VRML  ARQL  SGEN  SQNM  THLD  MNTA  PBTH  BIOD  
Linked by Chasing the Alpha - August 05, 03:21AM from (www.chasingthealpha.com)
Sorry that I have been light on blog posts recently. I've been dealing with moving into a new apartment, finishing up my  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Recap of last week's news and looking ahead to this week
CLSN  VRTX  ASTM  MNKD  EXEL  DEPO  SIGA  IGXT  NSPH  CYCC  YMI  BIOD  PIP  
Linked by Chasing the Alpha - May 15, 04:45AM from (www.chasingthealpha.com)
Here is a short summary of some events in biotech for the past week(5/9-5/13). I'll focus mainly on those stocks I follow and have done a good bit of reading up on.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Novo Nordisk Still One Of The Best Around
BMY  LLY  MRK  NVO  MNKD  SNY  BIOD  
Linked by Investopedia Stock Analysis - May 03, 11:21AM from (stocks.investopedia.com)
Novo Nordisk is one of the best pharmaceutical companies in the world - and it's priced accordingly.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
MannKind And The FDA - Here We Go Again
LLY  MRK  NVO  MNKD  NVS  SNY  BIOD  
Linked by Investopedia Stock Analysis - January 20, 12:21PM from (stocks.investopedia.com)
MNKD got another FDA setback in its attempts to bring inhaled insulin to the market.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
The Curious
MDT  PFE  NVO  MNKD  NKTR  SNY  BIOD  
Linked by Investopedia Stock Analysis - December 15, 12:15PM from (stocks.investopedia.com)
MannKind is a classic high-risk high-reward biotech story.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Merck Makes A Smart Buy
LLY  MDT  MRK  NVO  MNKD  SNY  PODD  HALO  BIOD  
Linked by Investopedia Stock Analysis - December 03, 05:00AM from (stocks.investopedia.com)
Merck is making an exciting bet on a possible diabetes breakthrough.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource